These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35180049)

  • 21. Asynchronous direct to patient teledermatology visits (e-visits) during COVID-19 pandemic: Lessons for future teledermatology practice.
    Trupiano N; Goldberg RH; Novice M; Mai J; Zhang H; Renati S; Castanedo-Tardan MP; Tejasvi T
    J Am Acad Dermatol; 2024 May; 90(5):1037-1039. PubMed ID: 38246561
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuing patient care to underserved communities and medical education during the COVID-19 pandemic through a teledermatology student-run clinic.
    Linggonegoro D; Rrapi R; Ashrafzadeh S; McCormack L; Bartenstein D; Hazen TJ; Kempf A; Kim EJ; Moore K; Sanchez-Flores X; Song H; Huang JT; Hussain S
    Pediatr Dermatol; 2021 Jul; 38(4):977-979. PubMed ID: 34101255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuances in Training During the Age of Teledermatology.
    Lim YH
    Cutis; 2022 Jan; 109(1):E43-E45. PubMed ID: 35180072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond?
    Lowe A; Pararajasingam A; Ali FM; Dawood S; Lowe CD; Stone NM
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e430-e432. PubMed ID: 33780552
    [No Abstract]   [Full Text] [Related]  

  • 25. Dermatology Teleteaching during the COVID-19 Pandemic.
    Plachouri KM; Mulita F; Georgiou S
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):185-186. PubMed ID: 33291205
    [No Abstract]   [Full Text] [Related]  

  • 26. Expanding teledermatology educational opportunities after the COVID-19 pandemic.
    Hassan S; Safadi MG; Mohammed TO; Lipoff JB
    J Am Acad Dermatol; 2021 Oct; 85(4):e253-e254. PubMed ID: 34314747
    [No Abstract]   [Full Text] [Related]  

  • 27. Teledermatology application use in the COVID-19 era.
    Pulsipher KJ; Presley CL; Rundle CW; Rietcheck HR; Millitelo M; Dellavalle RP
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teledermatology in times of COVID-19.
    Stadler PC; Senner S; Frey S; Clanner-Engelshofen BM; H Frommherz L; French LE; Reinholz M
    J Dermatol; 2021 May; 48(5):620-624. PubMed ID: 33715181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teledermatology: How It Is Impacting the Underserved.
    Hadeler E; Prose N; Floyd LP
    Pediatr Dermatol; 2021 Nov; 38(6):1597-1600. PubMed ID: 34648665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth.
    Guzman AK; Barbieri JS
    J Am Acad Dermatol; 2020 Sep; 83(3):963-965. PubMed ID: 32505780
    [No Abstract]   [Full Text] [Related]  

  • 31. Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned.
    Farshchian M; Potts G; Kimyai-Asadi A; Mehregan D; Daveluy S
    J Drugs Dermatol; 2020 Jun; 19(6):683. PubMed ID: 32574014
    [No Abstract]   [Full Text] [Related]  

  • 32. Is climate change the next pandemic for dermatology? Lessons from COVID-19.
    Patruno C; Nisticò SP; Fabbrocini G; Napolitano M
    Dermatol Ther; 2020 Jul; 33(4):e13682. PubMed ID: 32447805
    [No Abstract]   [Full Text] [Related]  

  • 33. Teledermatology in the times of COVID-19 - a systematic review.
    Elsner P
    J Dtsch Dermatol Ges; 2020 Aug; 18(8):841-845. PubMed ID: 33448667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing Participation in a Substance Misuse Programs: Lessons Learned for Implementing Telehealth Solutions During the COVID-19 Pandemic.
    Rosen D
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):24-26. PubMed ID: 33153870
    [No Abstract]   [Full Text] [Related]  

  • 35. Virtual conferences of dermatology during the COVID-19 pandemic.
    Goldust M; Shivakumar S; Kroumpouzos G; Murrell DF; Rudnicka L; Jafferany M; Navarini AA
    Dermatol Ther; 2020 Jul; 33(4):e13774. PubMed ID: 32506609
    [No Abstract]   [Full Text] [Related]  

  • 36. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology.
    Castelo-Branco L; Awada A; Pentheroudakis G; Perez-Gracia JL; Mateo J; Curigliano G; Banerjee S; Giuliani R; Lordick F; Cervantes A; Tabernero J; Peters S
    ESMO Open; 2021 Oct; 6(5):100237. PubMed ID: 34411971
    [No Abstract]   [Full Text] [Related]  

  • 37. Conducting inpatient dermatology consultations and maintaining resident education in the COVID-19 telemedicine era.
    Hammond MI; Sharma TR; Cooper KD; Beveridge MG
    J Am Acad Dermatol; 2020 Oct; 83(4):e317-e318. PubMed ID: 32652186
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists.
    Palmese CA; Wyman-Chick KA; Racine C; Pollak LE; Lin G; Farace E; Tran B; Floden D; Bobholz J; Turner TH; York MK;
    Clin Neuropsychol; 2022 Jan; 36(1):72-84. PubMed ID: 34030595
    [No Abstract]   [Full Text] [Related]  

  • 39. Pediatric teledermatology: A retrospective review of 1199 encounters during the COVID-19 pandemic.
    Havele SA; Fathy R; McMahon P; Murthy AS
    J Am Acad Dermatol; 2022 Sep; 87(3):678-680. PubMed ID: 34838881
    [No Abstract]   [Full Text] [Related]  

  • 40. Moving forward with teledermatology: Operational challenges of a hybrid in-person and virtual practice.
    Yi JZ; Reynolds RV; Olbricht SM; McGee JS
    Clin Dermatol; 2021; 39(4):707-709. PubMed ID: 34809777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.